Physician profile
Michael J Boss
NPI 1245447317
$37,667.75
in general payments reported to CMS, 2019-2025
7 companies · $19K in 2025
The $19K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $114 · 2021: $506 · 2022: $216 · 2023: $6,265 · 2024: $11K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $3,734 · Food and Beverage: $1,124 · Honoraria: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,199.75 |
| Travel and Lodging | $3,734.02 |
| Food and Beverage | $1,124.31 |
| Honoraria | $665.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $36,547.09 | 2022-2025 | Cleviprex, Kengreal |
| Edwards Lifesciences Corporation | $591.92 | 2019-2025 | |
| Medtronic, INC. | $222.78 | 2021-2022 | |
| Boston Scientific Corporation | $121.04 | 2022-2023 | Watchman Access System |
| Abiomed | $113.91 | 2020 | |
| Abbott Laboratories | $49.80 | 2023 | Mitraclip |
| Teleflex LLC | $21.21 | 2024 | Guideliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Boss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.